Response of histiocytoses to imatinib mesylate: fire to ashes

MeSH terms

• Administration, Oral
• Adult
• Aged
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use*
• Benzamides
• Brain Neoplasms / diagnosis
• Brain Neoplasms / drug therapy
• Diagnosis, Differential
• Drug Administration Schedule
• Erdheim-Chester Disease / diagnosis*
• Erdheim-Chester Disease / drug therapy*
• Female
• Genes, abl / genetics
• Histiocytosis, Langerhans-Cell / diagnosis*
• Histiocytosis, Langerhans-Cell / drug therapy*
• Humans
• Imatinib Mesylate
• Lung Neoplasms / diagnosis
• Lung Neoplasms / drug therapy
• Male
• Middle Aged
• Mutation
• Piperazines / administration & dosage
• Piperazines / therapeutic use*
• Positron-Emission Tomography
• Protein Kinase Inhibitors / administration & dosage
• Protein Kinase Inhibitors / therapeutic use*
• Protein-Tyrosine Kinases / antagonists & inhibitors*
• Protein-Tyrosine Kinases / genetics
• Proto-Oncogene Proteins c-kit / genetics
• Pyrimidines / administration & dosage
• Pyrimidines / therapeutic use*
• Receptor, Platelet-Derived Growth Factor alpha / genetics
• Receptor, Platelet-Derived Growth Factor beta / genetics
• Remission Induction
• Tomography, X-Ray Computed
• Treatment Outcome